Wealthfront Advisers LLC Cuts Position in Lam Research Corporation $LRCX

Wealthfront Advisers LLC lowered its position in Lam Research Corporation (NASDAQ:LRCX) by 13.3% in the second quarter, HoldingsChannel reports. The institutional investor owned 120,036 shares of the semiconductor company’s stock after selling 18,355 shares during the period. Wealthfront Advisers LLC’s holdings in Lam Research were worth $11,684,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the company. BankPlus Wealth Management LLC increased its position in shares of Lam Research by 2.0% in the second quarter. BankPlus Wealth Management LLC now owns 5,248 shares of the semiconductor company’s stock valued at $511,000 after buying an additional 105 shares in the last quarter. ORG Partners LLC boosted its stake in shares of Lam Research by 7.3% during the second quarter. ORG Partners LLC now owns 1,676 shares of the semiconductor company’s stock valued at $162,000 after acquiring an additional 114 shares during the last quarter. Quotient Wealth Partners LLC boosted its stake in shares of Lam Research by 2.1% during the second quarter. Quotient Wealth Partners LLC now owns 5,437 shares of the semiconductor company’s stock valued at $529,000 after acquiring an additional 114 shares during the last quarter. Fairvoy Private Wealth LLC boosted its stake in shares of Lam Research by 3.0% during the second quarter. Fairvoy Private Wealth LLC now owns 4,185 shares of the semiconductor company’s stock valued at $407,000 after acquiring an additional 120 shares during the last quarter. Finally, Rosenberg Matthew Hamilton boosted its stake in shares of Lam Research by 16.0% during the second quarter. Rosenberg Matthew Hamilton now owns 869 shares of the semiconductor company’s stock valued at $85,000 after acquiring an additional 120 shares during the last quarter. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Insider Buying and Selling at Lam Research

In related news, SVP Vahid Vahedi sold 52,190 shares of the firm’s stock in a transaction that occurred on Monday, October 13th. The stock was sold at an average price of $138.90, for a total value of $7,249,191.00. Following the transaction, the senior vice president directly owned 251,047 shares of the company’s stock, valued at approximately $34,870,428.30. This trade represents a 17.21% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.31% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on LRCX shares. Raymond James Financial increased their price objective on Lam Research from $90.00 to $110.00 and gave the company an “outperform” rating in a research note on Thursday, July 31st. Oppenheimer set a $200.00 price objective on Lam Research and gave the company an “outperform” rating in a research note on Thursday. TD Cowen upped their price target on Lam Research from $145.00 to $170.00 and gave the stock a “buy” rating in a report on Thursday. KeyCorp upped their target price on Lam Research from $105.00 to $115.00 and gave the company an “overweight” rating in a research report on Tuesday, July 15th. Finally, New Street Research boosted their price target on Lam Research from $105.00 to $140.00 and gave the company a “neutral” rating in a report on Thursday. One research analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat.com, Lam Research presently has a consensus rating of “Moderate Buy” and a consensus price target of $147.57.

Lam Research Trading Up 2.8%

Shares of Lam Research stock opened at $151.68 on Monday. The company has a quick ratio of 1.60, a current ratio of 2.21 and a debt-to-equity ratio of 0.37. The firm has a market cap of $191.27 billion, a price-to-earnings ratio of 33.41, a price-to-earnings-growth ratio of 1.66 and a beta of 1.84. The business has a fifty day simple moving average of $123.23 and a 200-day simple moving average of $100.07. Lam Research Corporation has a fifty-two week low of $56.32 and a fifty-two week high of $153.70.

Lam Research (NASDAQ:LRCX) last announced its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.22 by $0.04. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The company had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.23 billion. During the same period in the previous year, the firm earned $0.86 earnings per share. Lam Research’s revenue for the quarter was up 27.7% compared to the same quarter last year. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. On average, equities analysts forecast that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, October 15th. Investors of record on Wednesday, September 24th were paid a $0.26 dividend. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend was Wednesday, September 24th. This is a positive change from Lam Research’s previous quarterly dividend of $0.23. Lam Research’s dividend payout ratio (DPR) is 22.91%.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.